Analysis of sulphadoxine/pyrimethamine resistance-conferring mutations of <it>Plasmodium falciparum </it>from Mozambique reveals the absence of the dihydrofolate reductase 164L mutant
<p>Abstract</p> <p>Background</p> <p><it>Plasmodium falciparum </it>is the predominant human malaria species in Mozambique and a lead cause of mortality among children and pregnant women nationwide. Sulphadoxine/pyrimethamine (S/P) is used as first line anti...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2007-03-01
|
| Series: | Malaria Journal |
| Online Access: | http://www.malariajournal.com/content/6/1/35 |